Revised forecast
Fiscal year ending March 2027 · Second quarter (interim period)Previous forecast published 11 May 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
The CRO business is progressing steadily, expenses for the TR business are expected to be recognized in the second half of the fiscal year, and a foreign exchange gain of ¥172 million, which was not anticipated in the previous forecast, was recorded in the first quarter. There is no change to the assumed exchange rate of ¥150.00 per US dollar.
| Item | Details |
|---|---|
| Net Sales | 16,596 Millions of yen → 17,154 Millions of yen（+3.4%） |
| Operating profit | 463 Millions of yen → 1,240 Millions of yen（+167.8%） |
| Ordinary income | 1,948 Millions of yen → 2,988 Millions of yen（+53.4%） |
| Profit attributable to owners of the parent | 1,167 Millions of yen → 1,917 Millions of yen（+64.3%） |
| Net income per share | 28.03 yen and sen → 46.04 yen and sen |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Second quarter (interim period) |
| Publication date of previous forecast | 11 May 2026 |
| Previous-period results | Second-quarter results for the fiscal year ended March 2026: revenue ¥14,766 million, operating profit ¥49 million, ordinary profit ¥1,627 million, profit attributable to owners of the parent ¥1,061 million, and earnings per share ¥25.48 |
| Reason for the revision | The CRO business is progressing steadily, expenses for the TR business are expected to be recognized in the second half of the fiscal year, and a foreign exchange gain of ¥172 million, which was not anticipated in the previous forecast, was recorded in the first quarter. There is no change to the assumed exchange rate of ¥150.00 per US dollar. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue and operating profit are expected to exceed the previous forecast as the CRO business continues to perform steadily. In addition, expenses for the TR business are expected to be recognized in the second half of the fiscal year, and a foreign exchange gain of ¥172 million, which was not anticipated in the previous forecast, was recorded in the first quarter. The assumed exchange rate remains unchanged at ¥150.00 per US dollar.